PRIMARY OCULAR ADNEXAL MALT LYMPHOMA

Clinical trials for PRIMARY OCULAR ADNEXAL MALT LYMPHOMA explained in plain language.

Never miss a new study

Get alerted when new PRIMARY OCULAR ADNEXAL MALT LYMPHOMA trials appear

Sign up with your email to follow new studies for PRIMARY OCULAR ADNEXAL MALT LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

Eye lymphoma treatment showdown: injection vs. radiation

Disease control Recruiting now

This study tests if a direct injection of the drug rituximab into eye tumors works as well as standard radiation therapy for a rare eye lymphoma (MALT lymphoma). About 108 adults aged 18-75 will be randomly assigned to one of the two treatments. The goal is to see which approach …

Matched conditions: PRIMARY OCULAR ADNEXAL MALT LYMPHOMA

Phase: NA • Sponsor: Zhongshan Ophthalmic Center, Sun Yat-sen University • Aim: Disease control

Last updated May 26, 2026 10:16 UTC

PRIMARY OCULAR ADNEXAL MALT LYMPHOMA

Get alerted when new PRIMARY OCULAR ADNEXAL MALT LYMPHOMA trials appear

Eye lymphoma treatment showdown: injection vs. radiation